<DOC>
	<DOCNO>NCT00649844</DOCNO>
	<brief_summary>The purpose study compare efficacy safety ziprasidone clozapine schizophrenic patient resistant and/or intolerant antipsychotic treatment</brief_summary>
	<brief_title>A Study Comparing Efficacy Tolerability Ziprasidone vs. Clozapine Treatment Schizophrenia Patients Who Continue Have Symptoms Can Tolerate Other Antipsychotic Drugs</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Clozapine</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<criteria>CGI S ≥4 PANSS ≥ 80 Inpatients outpatients Patients history myeloproliferative disease , history granulocytopenia , agranulocytosis due drug Diagnosis substance dependence within previous 3 month use DSMIV criterion History seizure Organic mental disease , include mental retardation epilepsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>